Breaking News

Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity

Marks the first phase of a wider strategic initiative to expand capacity and enhance end-to-end biologics development and manufacturing services.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bionova Scientific, an Asahi Kasei Group company and full-service biologics contract development and manufacturing organization (CDMO), started commissioning of a third facility in Fremont, CA, which will enable the company to significantly scale-up its manufacturing capacity and service capabilities. The expansion also marks the start of a long-term strategic initiative by the company to broaden its services portfolio to cover an even wider range of technical capabilities and therapeutic modali...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters